References
- Seilbold J. R. Scleroderma. Kelley's textbook of rheumatology, 6th ed, S Ruddy, E. D Harris, C. B Sledge. Saunders, Philadelphia 2001; 1211–39
- Kahaleh M. B. Endothelin, an endothelial dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action. Arthritis Rheum 1991; 34: 978–83
- Shi‐Wen X., Denton C. P., Dashwood M. R., Holmes A. M., Bou‐Gharios G., Pearson J. D., et al. Fibroblast matrix gene expression and connective tissue remodelling: role of endothelin‐1. J Invest Dermatol 2001; 116: 417–25
- Hasegava M., Sato S., Takehara K. Augmented production of chemokines (monocyte chemotactic protein‐1 (MCP‐1), macrophage inflammatory‐1α (MIP‐1α) and MIP‐1β) in patients with systemic sclerosis: MCP‐1 and MIP‐1α may be involved in the development of pulmonary fibrosis. Clin Exp Immunol 1999; 117: 159–65
- Ong V. H., Evans L. A., Shiwen X., Fisher I. B., Rajkumar V., Abraham D. J., et al. Monocyte chemoattractant protein 3 as a mediator of fibrosis: overexpression in systemic sclerosis and the type 1 tight‐skin mouse. Arthritis Rheum 2003; 48: 1979–91
- Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowler B., et al. Hyperhomocystinemia: an independent risk factor for vascular disease. New Engl J Med 1991; 324: 1149–55
- Tawakol A., Omland T., Gerhard M., Wu J. T., Creager M. A. Hyperhomosyst(e)inemia is associated with impaired endothelium‐dependent vasodilatation in humans. Circulation 1997; 95: 1119–21
- Sung F. L., Siow Y. L., Wang G., Lyn E. G., K. O. Homocysteine stimulates the expression of monocyte chemoattractant protein‐1 in endothelial cells leading to enhanced monocyte chemotaxis. Mol Cell Biochem 2001; 216: 121–8
- Marasini B., Casari S., Bestetti A., Maioli C., Cugno M., Zeni S., et al. Homocysteine concentration in primary and systemic sclerosis associated Raynaud's phenomenon. J Rheumatol 2000; 27: 2621–3
- Caramaschi P., Martinelli N., Biasi D., Carletto A., Faccini G., Volpe A., et al. Homocysteine plasma concentration is related to severity of lung impairment in scleroderma. J Rheumatol 2003; 30: 298–304
- Bason C., Corrocher R., Lunardi C., Puccetti P., Olivieri O., Girelli D., et al. In atherosclerosis antibodies against HSP60 bind human cytomegalovirus‐derived proteins and induce apoptosis of non‐stressed endothelial cells. Lancet 2003; 362: 1971–7
- Drunat S., Moatti N., Paul J. L., Cogny A., Benoit M. O., Demuth K. Homocysteine‐induced decrease in endothelin‐1 production is initiated at the extracellular level and involves oxidative products. Eur J Biochem 2001; 268: 5287–94
- Distler O., Pap T., Kowal‐Bielecka O., Meyringer R., Guiducci S., Landthaler M., et al. Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis. Arthritis Rheum 2001; 11: 2665–78
- Chen P., Shibata M., Zidovetzki R., Fisher M., Zlokovic B. V., Hofman F. M. Endothelin‐1 and monocyte chemoattractant protein‐1 modulation in ischemia and human brain‐derived endothelial cell cultures. J Neuroimmunol 2001; 116: 62–73
- Girelli D., Friso S., Trabetti E., Olivieri O., Russo C., Pessotto U., et al. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from Northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic–environmental interaction. Blood 1998; 91: 4158–63